Rare Disease Report

Amyloidosis Studies at Takeda Oncology

SEPTEMBER 08, 2015
James Radke, PhD


In a recent interview with Rare Disease Report, Dixie Esseltine, MD, FRCPC, of Takeda Oncology explains the studies underway to test bortezomib (Velcade) and ixazomib in patients with amyloidosis.

Stay informed on the latest rare disease news and developments by signing up for our newsletter.
Copyright © RareDR 2013-2018 Rare Disease Communications. All Rights Reserved.